Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Multiple Myeloma 1Lymphoma 1Leukemia 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 37fludarabine phosphate 31Busulfan 25Antilymphocyte Serum 22Mycophenolic Acid 20Melphalan 19Cyclosporine 19Peripheral Blood Stem Cell Transplantation 16Filgrastim 16Cord Blood Stem Cell Transplantation 16Whole-Body Irradiation 14Tacrolimus 14Radiotherapy 14Methylprednisolone 13fludarabine 11Methotrexate 8Epoetin Alfa 8Etoposide 7Cytarabine 7Thiotepa 6Alemtuzumab 6thymoglobulin 4Granulocyte Colony-Stimulating Factor 4Darbepoetin alfa 3Bone Marrow Transplantation 3Stem Cell Transplantation 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Ficusin × Classical hematology × Clear all
NCT00676806 2017-06-01

A Phase II Study of Umbilical Cord Blood Transplantation

Tufts Medical Center

Phase 2 Terminated
7 enrolled 13 charts
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Leukemia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡